Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J. C. Defesche"'
Autor:
D. M. Kusters, R. Huijgen, J. C. Defesche, M. N. Vissers, I. Kindt, B. A. Hutten, J. J. P. Kastelein
Publikováno v:
De Nederlandse gezondheidszorg ISBN: 9789036807043
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edb8825a9f991ad7abe1cb7e476e616c
https://doi.org/10.1007/978-90-368-0705-0_13
https://doi.org/10.1007/978-90-368-0705-0_13
Autor:
M E, Visser, G M, Dallinga-Thie, S J, Pinto-Sietsma, J C, Defesche, E S, Stroes, P R, van der Valk
Publikováno v:
The Netherlands journal of medicine. 70(6)
We present the case of a patient with clinical features of familial dysbetalipoproteinaemia (FD) including high levels of total cholesterol, hypertriglyceridaemia and the presence of palmar xanthomas. Whereas genotype analysis identified the APOE3E3
Publikováno v:
Annals of neurology, 27(5), 578-581. John Wiley and Sons Inc.
We report on 5 brothers with slowly progressive limbgirdle weakness. Calf hypertrophy was absent. The levels of creatine kinase, electromyography, and findings from a muscle biopsy specimen were compatible with muscular dystrophy. The propositus's bi
Autor:
J.J.P. Kastelein, J. C. Defesche, P. R. W. De Sauvage Nolting, P. J. Lansberg, Rudolf J.A Buirma, Barbara A. Hutten
Publikováno v:
Journal of internal medicine, 253(2), 161-168. Wiley-Blackwell
de Sauvage Nolting PRW, Defesche JC, Buirma RJA, Hutten BA, Lansberg PJ, Kastelein JJP (Academic Medical Center, Amsterdam; Clinical Research, Haarlem; Slotervaart Hospital, Amsterdam; the Netherlands). Prevalence and significance of cardiovascular r
Publikováno v:
BMJ (Clinical research ed.). 322(7293)
To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease.Family tree mortality study.Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century.All
Autor:
K L, Khoo, P, van Acker, J C, Defesche, H, Tan, L, van de Kerkhof, S J, Heijnen-van Eijk, J J, Kastelein, J P, Deslypere
Publikováno v:
Clinical genetics. 58(2)
The aim of this study was to detect mutations in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in patients of Southeast Asian origin with clinically diagnosed familial hypercholesterolemia (FH) and to relate these fin
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 144(30)
To determine the prevalence of familial hypercholesterolaemia (FH).Patient record screening, questionnaire and if necessary, case finding.Over the period mid-1990-mid-1992 (approximately 2.5 years) 8,800 adult individuals (age 18 years and over) in 4
Autor:
M P, Lombardi, E J, Redeker, J C, Defesche, S W, Kamerling, M D, Trip, M M, Mannens, L M, Havekes, J J, Kastelein
Publikováno v:
Clinical genetics. 57(2)
Mutations in the LDL receptor are responsible for familial hypercholesterolemia (FH). At present, more than 600 mutations of the LDL receptor gene are known to underlie FH. However, the array of mutations varies considerably in different populations.
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 143(22)
To inventory the possibilities of tracing relatives of patients with familial hypercholesterolaemia (FH) by means of family tree research and DNA diagnostics.Descriptive.Blood from patients with the clinical diagnosis of 'FH' was sent, through one of
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 141(52)
Familial hypercholesterolaemia (FH) is a congenital metabolic disorder predisposing to severe atherosclerosis resulting in coronary heart disease sometimes even at early adult age. Children with FH lack the stigmata at physical examination and measur